At Penn's Abramson Cancer Center, patients with lung cancer have access to every treatment option available, provided by nationally recognized cancer experts. Penn's expert care and leading-edge treatments give patients with lung cancer the best chance of an excellent outcome.
Treatments for lung cancer at Penn's Abramson Cancer Center include:
Lung cancer specialists at Penn Medicine develop personalized treatment plans that often include a combination of therapies designed to meet the specific needs of each patient.
Patients treated in Penn's Lung Cancer Program benefit from a multidisciplinary team of specialists from the Abramson Cancer Center and the Joan Karnell Cancer Center at Pennsylvania Hospital.
Penn's comprehensive lung cancer treatment team includes internationally recognized specialists from the following disciplines:
Lung cancer patients who choose Penn Medicine have access to a nurse navigator who specializes in helping lung cancer patients. The nurse navigator helps ensure that patients have easier access to the many resources available at Penn, and helps coordinate lung cancer patient's care among the number of specialists who are involved in their treatment plan.
Proton Therapy for Lung Cancer
Proton therapy uses beams of protons that are precisely directed at a lung tumor. The precision of proton therapy limits the radiation exposure of normal tissues while allowing a higher dose to be delivered to the tumor in the lung. The result is a better chance of curing lung cancer with fewer harmful side effects. One of the most unique aspects of proton therapy is its ability to treat recurrent lung cancers. The Roberts Proton Therapy Center has recently developed re-treatment protocols aimed at treating recurrent thoracic malignancies. Since this therapy is so targeted, it allows a potential lung cancer patient to receive multiple treatments and re-treatments – giving hope when other therapies have failed.
Lung cancer specialists at the Abramson Cancer Center are using immunotherapy to stimulate the body to repair and enhance its own immune system. Immunotherapy may also prevent lung cancer from developing or spreading. Immunotherapy often has fewer side effects than conventional cancer treatments because it uses the body's own immune system to achieve several things:
Targeted Molecular Therapy is a type of personalized lung cancer treatment. It is designed to interrupt the unique molecular abnormalities that make cancer grow.
Targeted drug therapies are personalized to each individual through rigorous analysis of a lung tumor's unique molecular fingerprint. These targeted therapies have the potential to cause less impact on normal cells and fewer side effects, while improving effectiveness and quality of life.
Penn researchers are on the forefront of new developments for lung cancer. These include testing new surgical procedures, applying innovative drug therapies, developing new protocols for proton therapy and exploring novel radiation therapies. Through our researchers' efforts, we are accelerating the development of new and more effective treatments for lung cancer.
Novel approaches for lung cancer treatment being pioneered at Penn Medicine, include:
The excellence of our highly trained cancer center staff has been recognized at a national level:
At Penn, there's more hope than ever for people facing lung cancer. Connect with a Lung Cancer Nurse Navigator to learn your best course for treatment.